q&more
My watch list
my.chemie.de  
Login  

News

How nerve cells control misfolded proteins

© RUB, Marquard

Dr. Verian Bader and Ana Sánchez Vicente are members of the research team headed by Professor Konstanze Winklhofer (in the background) which has revealed a new role of the protein complex Lubac.

28-Mar-2019: Neurodegenerative diseases such as Huntington’s or Parkinson’s disease are associated with misfolded and aggregated proteins. Researchers have discovered a new mechanism used by cells to protect themselves.

Researchers have identified a protein complex that marks misfolded proteins, stops them from interacting with other proteins in the cell and directs them towards disposal. In collaboration with the neurology department at the Ruhr-Ubiversität’s St. Josef-Hospital as well as colleagues at the Max Planck Institute of Biochemistry in Martinsried, an interdisciplinary team under the auspices of Professor Konstanze Winklhofer at Ruhr-Universität Bochum has identified the so-called Linear Ubiquitin Chain Assembly Complex, Lubac for short, as a crucial player in controlling misfolded proteins in cells.

The group is hoping to find a new therapeutic approach to treat neurodegenerative diseases such as Alzheimer’s, Parkinson’s or Huntington’s chorea, all of which are associated with misfolded proteins.

New function of protein complex

Earlier studies have revealed that the protein complex Lubac regulates signalling pathways of the innate immune response that are mediated by the transcription factor NF-kB. For example, Lubac can be recruited to trigger immune responses by binding to bacteria in the cells and activating NF-kB.

“Our study revealed that the Lubac system has a previously unknown function,” says Konstanze Winklhofer, who is also member of the Cluster of Excellence Ruhr Explores Solvation, Resolv for short. “It appears that Lubac recognises misfolded proteins as dangerous and marks them with linear ubiquitin chains, thus rendering them harmless to nerve cells.” Unlike its response to bacteria, this function of Lubac is independent of the transcription factor NF-kB.

Aggregates of misfolded proteins are toxic to cells, because they interfere with various processes. For example, they expose an interactive surface thereby sequestering and inactivating other proteins that are essential for the cell. This process disrupts the function of nerve cells and can cause cell death.

Preventing protein interactions

The research team has now decoded the mechanism described above using the huntingtin protein, the misfolding of which causes Huntington’s disease. By attaching linear ubiquitin chains to aggregated huntingtin, the aggregates are shielded from unwanted interactions in the cell and can be degraded more easily. In Huntington’s patients, the Lubac system is impaired, as the team demonstrated.

These insights were gained by combining cell biology and biochemistry methods and using high-resolution microscopy (Structured Illumination Super-Resolution Microscopy).

Mechanism works for various proteins

The protective effect of Lubac is not limited to huntingtin aggregates. The researchers also detected linear ubiquitin chains attached to protein aggregates that play a role in other neurodegenerative disorders, for example in amyotrophic lateral sclerosis.

“The attachment of linear ubiquitin chains is a highly specific process, as there is only one protein – namely a Lubac-component – that can mediate it,” explains Konstanze Winklhofer. “Based on these insights, strategies for new therapeutic approaches could be developed.”

In future studies, the team intends to identify small molecules that affect linear ubiquitination and to test if they have any positive effects on neurodegeneration. “But there is still a long way ahead until a drug can be developed,” concludes Konstanze Winklhofer.

Original publication:
Eva van Well, Verian Bader et al.; "A protein quality control pathway regulated by linear ubiquitination"; The EMBO Journal, 2019

Facts, background information, dossiers

  • protein aggregation
  • protein complexes
  • proteins
  • neurodegenerative diseases
  • Alzheimer's disease
  • Parkinson's disease
  • Chorea Huntington
  • protein folding

More about Ruhr-Universität Bochum

  • News

    High reaction rates even without precious metals

    Precious metals are often efficient catalysts. But they are expensive and rare. However, it has so far been difficult to determine how efficient non-precious metal alternatives are. Non-precious metal nanoparticles could one day replace expensive catalysts for hydrogen production. However, ... more

    Drug resistance: Preventing drugs from being transported

    Certain membrane proteins specialise in transporting molecules out of cells – a problem for the efficacy of cancer medication and antibiotics. An international research team has investigated the transport mechanism of a bacterial membrane protein using an artificially produced antibody frag ... more

    Monitoring the lifecycle of tiny catalyst nanoparticles

    Since they are so tiny, it is difficult to investigate single nanoparticles. However, this is exactly what researchers are aiming for in order to tailor their properties. A novel approach: particle at the stick. Nanoparticles can be used in many ways as catalysts. To be able to tailor them ... more

  • q&more articles

    Light plus current: The formula for researching what happens to individual nanoparticles

    A combination of dark-field microscopy and electrochemistry can make individual nanoparticles in a liquid medium visible. The technique is suited to determine the activity of catalysts during their use. more

    Vibrational spectroscopy - Label-free imaging

    Spectroscopic methods are now granting us deep insights into biological systems at previously unattainable spatial and temporal resolutions. Complementing the already well-established fluorescence spectroscopy, the major potential of label-free vibrational spectroscopy has become clear in r ... more

  • Authors

    Kevin Wonner

    Kevin Wonner, born in 1995, studied chemistry with the focus on electrochemical nanoparticle characterization at the Ruhr University Bochum. He started his PhD in 2018 at the chair of Analytical Chemistry II of Professor Dr. Kristina Tschulik and is supported by the graduate school 2376. Hi ... more

    Mathies V. Evers

    Mathies Evers, born in 1989, studied chemistry at the Ruhr University Bochum, where he researched the synthesis of atom-precise molecular clusters. After his master's degree he started his doctoral thesis at the Chair of Analytical Chemistry II of Professor Dr. Kristina Tschulik and is supp ... more

    Prof. Dr. Kristina Tschulik

    Kristina Tschulik received her doctorate from TU Dresden in 2012 and worked as a postdoctoral fellow at the Leibniz Institute for Solid State and Materials Research Dresden and at the University of Oxford. Afterwards she established the working group for “Electrochemistry and Nanoscale Mate ... more

q&more – the networking platform for quality excellence in lab and process

The q&more concept is to increase the visibility of recent research and innovative solutions, and support the exchange of knowledge. In the broad spectrum of subjects covered, the focus is on achieving maximum quality in highly innovative sectors. As a modern knowledge platform, q&more offers market participants one-of-a-kind networking opportunities. Cutting-edge research is presented by authors of international repute. Attractively presented in a high-quality context, and published in German and English, the original articles introduce new concepts and highlight unconventional solution strategies.

> more about q&more

q&more is supported by:

 

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE